| authorizations: |
registration not required
|
| accessURL: |
http://www.iedb.org/reference/1007076 |
| landingPage: |
http://www.iedb.org/assay/1801545 |
| type: |
Literature
|
| publicationVenue: |
J Clin Immunol
|
| dates: |
2004
|
| study type: | b cell assays |
| subject species: | Homo sapiens |
| fullName: |
Dror Luger
Molly Dayan
Heidy Zinger
Jian-Ping Liu
Edna Mozes
|
| method: |
in vivo assay
|
| name: |
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation.
|
| description: |
The peptide was based on the complementarity determining region (CDR) 1 of the human anti-DNA monoclonal antibody that bears the 16/6Id.
Treatment with the epitope at any dose did not induce tolerance to human mAb 16/6Id, as measured by Ab titer.
|
| name: |
iedb
|
| homePage: |
http://www.iedb.org |